Dietary administration of the proapoptotic vitamin E analogue α-tocopheryloxyacetic acid inhibits metastatic murine breast cancer

Tobias Hahn, Lajos Szabo, Mikhal Gold, Lalitha Ramanathapuram, Laurence Hurley, Emmanuel T. Akporiaye

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The ability of the vitamin E (RRR-α-tocopherol) derivatives α-tocopheryl succinate (α-TOS) and α-tocopheryloxyacetic acid (α-TEA) to suppress tumor growth in preclinical animal models has recently led to increased interest in their potential use for treating human cancer. To make the use of these vitamin E analogues more clinically relevant, we compared the antitumor efficacy of orally and i.p. delivered forms of α-TEA and α-TOS against a murine mammary cancer (4T1) that bears resemblance to human breast cancer because of its poor immunogenicity and high metastatic potential. In cell culture studies, we showed that both compounds inhibited tumor colony formation and induced apoptotic death of tumor cells. To avoid solubility concerns associated with the hydrophobicity of α-TEA and α-TOS, we used the vesiculated forms of α-TEA (Vα-TEA) and α-TOS (Vα-TOS) for the in vivo tumor studies. Both compounds inhibited the growth of preestablished 4T1 tumors when given i.p. However, when given by oral gavage, only the esterase-resistant Vα-TEA was able to suppress primary tumor growth and reduce lung metastasis. To make this approach more translatable to the clinic, α-TEA was incorporated into the diet and fed to tumor-bearing mice. We report here for the first time that dietary α-TEA delivery significantly inhibited primary tumor growth and dramatically reduced spontaneous metastatic spread to the lung in prophylactic and therapeutic settings. This study suggests that dietary α-TEA could prove useful as a relatively easy and effective modality for treating metastatic breast cancer.

Original languageEnglish (US)
Pages (from-to)9374-9378
Number of pages5
JournalCancer Research
Volume66
Issue number19
DOIs
StatePublished - Oct 1 2006

Fingerprint

Vitamin E
Breast Neoplasms
Acids
Neoplasms
Growth
Lung
Tocopherols
Succinic Acid
Esterases
Hydrophobic and Hydrophilic Interactions
Solubility
Cell Death
Animal Models
Cell Culture Techniques
Neoplasm Metastasis
Diet

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Dietary administration of the proapoptotic vitamin E analogue α-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. / Hahn, Tobias; Szabo, Lajos; Gold, Mikhal; Ramanathapuram, Lalitha; Hurley, Laurence; Akporiaye, Emmanuel T.

In: Cancer Research, Vol. 66, No. 19, 01.10.2006, p. 9374-9378.

Research output: Contribution to journalArticle

Hahn, Tobias ; Szabo, Lajos ; Gold, Mikhal ; Ramanathapuram, Lalitha ; Hurley, Laurence ; Akporiaye, Emmanuel T. / Dietary administration of the proapoptotic vitamin E analogue α-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. In: Cancer Research. 2006 ; Vol. 66, No. 19. pp. 9374-9378.
@article{7bbd98292a084b2592fa8a21a92e43e2,
title = "Dietary administration of the proapoptotic vitamin E analogue α-tocopheryloxyacetic acid inhibits metastatic murine breast cancer",
abstract = "The ability of the vitamin E (RRR-α-tocopherol) derivatives α-tocopheryl succinate (α-TOS) and α-tocopheryloxyacetic acid (α-TEA) to suppress tumor growth in preclinical animal models has recently led to increased interest in their potential use for treating human cancer. To make the use of these vitamin E analogues more clinically relevant, we compared the antitumor efficacy of orally and i.p. delivered forms of α-TEA and α-TOS against a murine mammary cancer (4T1) that bears resemblance to human breast cancer because of its poor immunogenicity and high metastatic potential. In cell culture studies, we showed that both compounds inhibited tumor colony formation and induced apoptotic death of tumor cells. To avoid solubility concerns associated with the hydrophobicity of α-TEA and α-TOS, we used the vesiculated forms of α-TEA (Vα-TEA) and α-TOS (Vα-TOS) for the in vivo tumor studies. Both compounds inhibited the growth of preestablished 4T1 tumors when given i.p. However, when given by oral gavage, only the esterase-resistant Vα-TEA was able to suppress primary tumor growth and reduce lung metastasis. To make this approach more translatable to the clinic, α-TEA was incorporated into the diet and fed to tumor-bearing mice. We report here for the first time that dietary α-TEA delivery significantly inhibited primary tumor growth and dramatically reduced spontaneous metastatic spread to the lung in prophylactic and therapeutic settings. This study suggests that dietary α-TEA could prove useful as a relatively easy and effective modality for treating metastatic breast cancer.",
author = "Tobias Hahn and Lajos Szabo and Mikhal Gold and Lalitha Ramanathapuram and Laurence Hurley and Akporiaye, {Emmanuel T.}",
year = "2006",
month = "10",
day = "1",
doi = "10.1158/0008-5472.CAN-06-2403",
language = "English (US)",
volume = "66",
pages = "9374--9378",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "19",

}

TY - JOUR

T1 - Dietary administration of the proapoptotic vitamin E analogue α-tocopheryloxyacetic acid inhibits metastatic murine breast cancer

AU - Hahn, Tobias

AU - Szabo, Lajos

AU - Gold, Mikhal

AU - Ramanathapuram, Lalitha

AU - Hurley, Laurence

AU - Akporiaye, Emmanuel T.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - The ability of the vitamin E (RRR-α-tocopherol) derivatives α-tocopheryl succinate (α-TOS) and α-tocopheryloxyacetic acid (α-TEA) to suppress tumor growth in preclinical animal models has recently led to increased interest in their potential use for treating human cancer. To make the use of these vitamin E analogues more clinically relevant, we compared the antitumor efficacy of orally and i.p. delivered forms of α-TEA and α-TOS against a murine mammary cancer (4T1) that bears resemblance to human breast cancer because of its poor immunogenicity and high metastatic potential. In cell culture studies, we showed that both compounds inhibited tumor colony formation and induced apoptotic death of tumor cells. To avoid solubility concerns associated with the hydrophobicity of α-TEA and α-TOS, we used the vesiculated forms of α-TEA (Vα-TEA) and α-TOS (Vα-TOS) for the in vivo tumor studies. Both compounds inhibited the growth of preestablished 4T1 tumors when given i.p. However, when given by oral gavage, only the esterase-resistant Vα-TEA was able to suppress primary tumor growth and reduce lung metastasis. To make this approach more translatable to the clinic, α-TEA was incorporated into the diet and fed to tumor-bearing mice. We report here for the first time that dietary α-TEA delivery significantly inhibited primary tumor growth and dramatically reduced spontaneous metastatic spread to the lung in prophylactic and therapeutic settings. This study suggests that dietary α-TEA could prove useful as a relatively easy and effective modality for treating metastatic breast cancer.

AB - The ability of the vitamin E (RRR-α-tocopherol) derivatives α-tocopheryl succinate (α-TOS) and α-tocopheryloxyacetic acid (α-TEA) to suppress tumor growth in preclinical animal models has recently led to increased interest in their potential use for treating human cancer. To make the use of these vitamin E analogues more clinically relevant, we compared the antitumor efficacy of orally and i.p. delivered forms of α-TEA and α-TOS against a murine mammary cancer (4T1) that bears resemblance to human breast cancer because of its poor immunogenicity and high metastatic potential. In cell culture studies, we showed that both compounds inhibited tumor colony formation and induced apoptotic death of tumor cells. To avoid solubility concerns associated with the hydrophobicity of α-TEA and α-TOS, we used the vesiculated forms of α-TEA (Vα-TEA) and α-TOS (Vα-TOS) for the in vivo tumor studies. Both compounds inhibited the growth of preestablished 4T1 tumors when given i.p. However, when given by oral gavage, only the esterase-resistant Vα-TEA was able to suppress primary tumor growth and reduce lung metastasis. To make this approach more translatable to the clinic, α-TEA was incorporated into the diet and fed to tumor-bearing mice. We report here for the first time that dietary α-TEA delivery significantly inhibited primary tumor growth and dramatically reduced spontaneous metastatic spread to the lung in prophylactic and therapeutic settings. This study suggests that dietary α-TEA could prove useful as a relatively easy and effective modality for treating metastatic breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=33750295846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750295846&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-06-2403

DO - 10.1158/0008-5472.CAN-06-2403

M3 - Article

C2 - 17018590

AN - SCOPUS:33750295846

VL - 66

SP - 9374

EP - 9378

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 19

ER -